Top

Hernia

Published in:

Open Access 01-12-2021 | Original Article

Outcomes of mid-term and long-term degradable biosynthetic meshes in single-stage open complex abdominal wall reconstruction

Authors: J. J. M. Claessen, A. S. Timmer, J. J. Atema, M. A. Boermeester

Published in: Hernia | Issue 6/2021

Abstract

Objective

To assess clinical outcomes in patients that underwent open single-stage complex abdominal wall reconstruction (CAWR) with biosynthetic mesh.

Methods

Retrospective observational study of two prospectively registered series of consecutive patients undergoing CAWR with either long-term degradable (LTD) Phasix^™ or mid-term degradable (MTD) BIO-A^® biosynthetic mesh in a single institution between June 2016 and December 2019.

Results

From 169 patients with CAWR, 70 consecutive patients were identified who underwent CAWR with either LTD or MTD biosynthetic mesh. More than 85% of patients had an incisional hernia that could be classified as moderately complex to major complex due to a previous wound infection (67%), one or more complicating comorbidities (87.1%), one or more complicating hernia characteristics (75.7%) or contaminated or dirty defects (37.1%). Concomitant component separation was performed in 43 of 70 patients (61.4%). Overall surgical site infection (SSI) rate in these CAWR patients was 45.7%. Seventeen of 70 patients (24.3%) had computed tomography (CT) - and culture-confirmed SSI in direct contact of mesh, suspicious of mesh infection. Mesh removal for persistent local infection occurred in 10% (7 of 70) after a median of 229 days since surgery. Salvage rate of mesh after direct contact with infection was 58.8%. All removed meshes were in the LTD group. Seven patients (10%) had a recurrence; four patients in the LTD group (10%) had a recurrence at a median follow-up of 35 months and three patients in the MTD group (10%) at a median follow-up of 11 months. Three of the seven recurrences occurred in patients with SSI in persistent and direct contact with mesh.

Conclusions

Comorbid patients undergoing open complex abdominal wall reconstruction are at high risk of postoperative wound complications regardless of which type of biosynthetic mesh is used. When in persistent and direct contact with infection, long-term biodegradable biosynthetic meshes may need to be removed, whereas mid-term biodegradable biosynthetic meshes can be salvaged.

Available only for authorised users

Poulose BK, Shelton J, Phillips S, Moore D, Nealon W, Penson D et al (2012) Epidemiology and cost of ventral hernia repair: making the case for hernia research. Hernia 16(2):179–183CrossRef

Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004) Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg. 240(4):578–583 (discussion 83-5)CrossRef

Huntington CR, Cox TC, Blair LJ, Schell S, Randolph D, Prasad T et al (2016) Biologic mesh in ventral hernia repair: outcomes, recurrence, and charge analysis. Surgery 160(6):1517–1527CrossRef

Nahabedian MY, Sosin M, Bhanot P (2018) A current review of biologic meshes in abdominal wall reconstruction. Plast Reconstr Surg 142(3 Suppl):74S-81SCrossRef

Atema JJ, Furnee EJ, Maeda Y, Warusavitarne J, Tanis PJ, Bemelman WA et al (2017) Major complex abdominal wall repair in contaminated fields with use of a non-cross-linked biologic mesh: a dual-institutional experience. World J Surg 41(8):1993–1999CrossRef

Itani KM, Rosen M, Vargo D, Awad SS, Denoto G 3rd, Butler CE et al (2012) Prospective study of single-stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH study. Surgery 152(3):498–505CrossRef

Rosen MJ, Krpata DM, Ermlich B, Blatnik JA (2013) A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh. Ann Surg 257(6):991–996CrossRef

de Vries FEE, Hodgkinson JD, Claessen JJM, van Ruler O, Leo CA, Maeda Y et al (2020) Long-term outcomes after contaminated complex abdominal wall reconstruction. Hernia 24(3):459–468CrossRef

Levy AS, Bernstein JL, Premaratne ID, Rohde CH, Otterburn DM, Morrison KA et al (2020) Poly-4-hydroxybutyrate (Phasix) mesh onlay in complex abdominal wall repair. Surg Endosc 8:1

10.

Messa CAT, Kozak G, Broach RB, Fischer JP (2019) When the mesh goes away: an analysis of poly-4-hydroxybutyrate mesh for complex hernia repair. Plast Reconstr Surg Glob Open 7(11):e2576CrossRef

11.

Rognoni C, Cuccurullo D, Borsoi L, Bonavina L, Asti E, Crovella F et al (2020) Clinical outcomes and quality of life associated with the use of a biosynthetic mesh for complex ventral hernia repair: analysis of the “Italian Hernia Club” registry. Sci Rep 10(1):10706CrossRef

12.

Rosen MJ, Bauer JJ, Harmaty M, Carbonell AM, Cobb WS, Matthews B et al (2017) Multicenter, prospective, longitudinal study of the recurrence, surgical site infection, and quality of life after contaminated ventral hernia repair using biosynthetic absorbable mesh: the COBRA study. Ann Surg 265(1):205–211CrossRef

13.

Roth JS, Anthone GJ, Selzer DJ, Poulose BK, Bittner JG, Hope WW et al (2018) Prospective evaluation of poly-4-hydroxybutyrate mesh in CDC class I/high-risk ventral and incisional hernia repair: 18-month follow-up. Surg Endosc 32(4):1929–1936CrossRef

14.

van Rooijen MM, Jairam AP, Tollens T, Jorgensen LN, de Vries Reilingh TS, Piessen G et al (2020) Outcomes of a new slowly resorbable biosynthetic mesh (Phasix) in potentially contaminated incisional hernias: a prospective, multi-center, single-arm trial. Int J Surg 83:31–36CrossRef

15.

von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344–349CrossRef

16.

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for prevention of surgical site infection, 1999 centers for disease control and prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control 27(2):97–132 (quiz 3-4; discussion 96)CrossRef

17.

Sabbagh C, Dumont F, Robert B, Badaoui R, Verhaeghe P, Regimbeau JM (2011) Peritoneal volume is predictive of tension-free fascia closure of large incisional hernias with loss of domain: a prospective study. Hernia 15(5):559–565CrossRef

18.

Kanters AE, Krpata DM, Blatnik JA, Novitsky YM, Rosen MJ (2012) Modified hernia grading scale to stratify surgical site occurrence after open ventral hernia repairs. J Am Coll Surg 215(6):787–793CrossRef

19.

Petro CC, O’Rourke CP, Posielski NM, Criss CN, Raigani S, Prabhu AS et al (2016) Designing a ventral hernia staging system. Hernia 20(1):111–117CrossRef

20.

Slater NJ, Montgomery A, Berrevoet F, Carbonell AM, Chang A, Franklin M et al (2014) Criteria for definition of a complex abdominal wall hernia. Hernia 18(1):7–17CrossRef

21.

Sneiders D, Jairam AP, de Smet GHJ, Dawson I, van Eeghem LHA, Vrijland WW et al (2020) incisional hernia cannot be diagnosed by a patient-reported diagnostic questionnaire. J Surg Res 245:656–662CrossRef

22.

Atema JJ, Mirck B, Van Arum I, Ten Dam SM, Serlie MJ, Boermeester MA (2016) Outcome of acute intestinal failure. Br J Surg 103(6):701–708CrossRef

23.

de Vries FEE, Claessen JJM, van Hasselt-Gooijer EMS, van Ruler O, Jonkers C, Kuin W et al (2020) Bridging-to-surgery in patients with type 2 intestinal failure. J Gastrointest Surg. 22:1–1

24.

Group EF, Vaizey CJ, Maeda Y, Barbosa E, Bozzetti F, Calvo J et al (2016) European Society of Coloproctology consensus on the surgical management of intestinal failure in adults. Colorectal Dis 18(6):535–548CrossRef

25.

Montgomery A (2013) The battle between biological and synthetic meshes in ventral hernia repair. Hernia 17(1):3–11CrossRef

26.

Buell JF, Sigmon D, Ducoin C, Shapiro M, Teja N, Wynter E et al (2017) Initial experience with biologic polymer scaffold (poly-4-hydroxybuturate) in complex abdominal wall reconstruction. Ann Surg 266(1):185–188CrossRef

27.

Bueno-Lledo J, Ceno M, Perez-Alonso C, Martinez-Hoed J, Torregrosa-Gallud A, Pous-Serrano S (2020) Biosynthetic resorbable prosthesis is useful in single-stage management of chronic mesh infection after abdominal wall hernia repair. World J Surg 45(2):443–450CrossRef

28.

Pakula A, Skinner R (2020) Outcomes of open complex ventral hernia repairs with retromuscular placement of poly-4-hydroxybutyrate bioabsorbable mesh. Surg Innov 27(1):32–37CrossRef

29.

Plymale MA, Davenport DL, Dugan A, Zachem A, Roth JS (2018) Ventral hernia repair with poly-4-hydroxybutyrate mesh. Surg Endosc 32(4):1689–1694CrossRef

30.

Cho JE, Helm MC, Helm JH, Mier N, Kastenmeier AS, Gould JC et al (2019) Retro-rectus placement of bio-absorbable mesh improves patient outcomes. Surg Endosc 33(8):2629–2634CrossRef

31.

Garcia-Urena MA, Lopez-Monclus J, Cuccurullo D, Blazquez Hernando LA, Garcia-Pastor P, Reggio S et al (2019) Abdominal wall reconstruction utilizing the combination of absorbable and permanent mesh in a retromuscular position: a multicenter prospective study. World J Surg 43(1):149–158CrossRef

32.

Munoz-Rodriguez JM, Lopez-Monclus J, San Miguel Mendez C, Perez-Flecha Gonzalez M, Robin-Valle de Lersundi A, Blazquez Hernando LA et al (2020) Outcomes of abdominal wall reconstruction in patients with the combination of complex midline and lateral incisional hernias. Surgery 168(3):532–542CrossRef

33.

Sahoo S, Haskins IN, Huang LC, Krpata DM, Derwin KA, Poulose BK et al (2017) Early wound morbidity after open ventral hernia repair with biosynthetic or polypropylene mesh. J Am Coll Surg 225(4):472–80 e1CrossRef

34.

Warren J, Desai SS, Boswell ND, Hancock BH, Abbad H, Ewing JA et al (2020) Safety and efficacy of synthetic mesh for ventral hernia repair in a contaminated field. J Am Coll Surg 230(4):405–413CrossRef

35.

Reilingh TSD, van Goor H, Charbon JA, Rosman C, Hesselink EJ, van der Wilt GJ et al (2007) Repair of giant midline abdominal wall hernias: “components separation technique” versus prosthetic repair—interim analysis of a randomized controlled trial. World J Surg 31(4):756–763CrossRef

36.

Atema JJ, de Vries FEE, Boermeester MA (2016) Systematic review and meta-analysis of the repair of potentially contaminated and contaminated abdominal wall defects. Am J Surg 212(5):982CrossRef

Title: Outcomes of mid-term and long-term degradable biosynthetic meshes in single-stage open complex abdominal wall reconstruction
Authors: J. J. M. Claessen
A. S. Timmer
J. J. Atema
M. A. Boermeester
Publication date: 01-12-2021
Publisher: Springer Paris
Published in: Hernia / Issue 6/2021
Print ISSN: 1265-4906
Electronic ISSN: 1248-9204
DOI: https://doi.org/10.1007/s10029-021-02415-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Outcomes of mid-term and long-term degradable biosynthetic meshes in single-stage open complex abdominal wall reconstruction

Abstract

Objective

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2021

Comparative effectiveness of surgeon-performed transversus abdominis plane blocks and epidural catheters following open hernia repair with transversus abdominis release

Prophylactic negative pressure wound therapy after open ventral hernia repair: a systematic review and meta-analysis

Prioritization criteria of patients on scheduled waiting lists for abdominal wall hernia surgery: a cross-sectional study

Outcomes of redo-transversus abdominis release for abdominal wall reconstruction

Hybrid robotic transversus abdominis release versus open: propensity-matched analysis of 30-day outcomes

CT scan structured report for the study of abdominal wall defects: a fast, easy and practical tool at the service of both surgeons and radiologist